James E. Fickenscher, Chief Financial Officer at Zynerba Pharmaceuticals, Inc. (ZYNE), bought 7,000 shares at $14.03 ($99K) on 2016-12-07, disclosed to the SEC on 2016-12-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.15 | 3,000 | $42K | 43.1% |
| 2 | $14.03 | 4,000 | $56K | 56.9% |
| Total | $14.08 avg | 7,000 | $99K | 100% |
| Filing → |
| ZYNE | SELL | 2022-07-20 | $7K | — | Filing → |
| ZYNE | BUY | 2018-08-07 | $102K | — | Filing → |
| ZYNE | BUY | 2017-05-16 | $103K | — | Filing → |